Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 768.25 INR
Change Today +14.75 / 1.96%
Volume 6.9K
As of 6:21 AM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

sequent scientific ltd (SEQ) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/7/15 - 850.00
52 Week Low
08/19/14 - 350.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SEQUENT SCIENTIFIC LTD (SEQ)

Related News

No related news articles were found.

sequent scientific ltd (SEQ) Related Businessweek News

No Related Businessweek News Found

sequent scientific ltd (SEQ) Details

SeQuent Scientific Limited operates as an integrated pharmaceutical company in India and internationally. It produces human and animal health active pharmaceutical ingredients (APIs). The company’s human APIs portfolio covers anti-malarial, anthelmintic, anti-infective, antiviral, niche CVS, CNS, and dermatology therapeutic segments; and animal health APIs covers anthelmintic, antiprotozoal, nutraceutical, NSAID, anti-infective, dermatology, and other therapeutic segments. The company also provides specialized analytical solutions to technical and regulatory problems. It also manufactures a range of veterinary products in finished dosage form for use in the therapeutic category. In addition, the company provides contract research and custom synthesis, contract manufacturing, and custom process development services, as well as specialty chemicals for various industries. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to SeQuent Scientific Limited in October 2009. SeQuent Scientific Limited was incorporated in 1985 and is headquartered in Bengaluru, India.

1,088 Employees
Last Reported Date: 05/19/15
Founded in 1985

sequent scientific ltd (SEQ) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sequent scientific ltd (SEQ) Key Developments

Sequent Scientific Mulls Acquisitions

Sequent Scientific Ltd. (BSE:512529) is looking for acquisitions. According to Sequent Scientific's Chief Executive Officer, Manish Gupta, there are plans to invest in US and Australian markets without return expectations for next three years. Gupta said Sequent is also looking at strategic acquisitions in Australia and US.

Sequent Scientific Ltd., Board Meeting, Jun 30, 2015

Sequent Scientific Ltd., Board Meeting, Jun 30, 2015. Agenda: To consider the consolidation of shareholding in Alivira by acquiring all the shares held in Alivira from Unit Trust of India Investment Advisory Services Limited A/c Ascent India Fund III and Devicam Capital LLP that is 9,997,941 shares; and to consider the preferential issue of 3,585,413 equity shares of INR 10 each for consideration other than cash, at a price of INR 669.10 per equity share (including a premium of INR 659.10 per equity share) in compliance with Chapter VII of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2009.

Sequent Scientific Ltd., Board Meeting, Jun 10, 2015

Sequent Scientific Ltd., Board Meeting, Jun 10, 2015. Agenda: To allot 800,000 equity shares at INR 222.15 per share and 200,000 equity shares at INR 236 per share to M/s. Chayadeep Ventures LLP, a Promoter Group Entity and 1,100,000 equity shares at INR 475 per share to Mr. Shivanand Shankar Mankekar HUF jointly with Mr. Kedar Shivanand Mankekar, a Non-Promoter pursuant to conversion of equivalent number of warrants.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SEQ:IN 768.25 INR +14.75

SEQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SEQ.
View Industry Companies

Industry Analysis


Industry Average

Valuation SEQ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.0x
Price/Book 24.4x
Price/Cash Flow 143.4x
TEV/Sales 5.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEQUENT SCIENTIFIC LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at